Jon Skorve Selected Research

1-(carboxymethylthio)tetradecane

7/2011	Anti-inflammatory and hypolipidemic effects of the modified fatty acid tetradecylthioacetic acid in psoriasis--a pilot study.
2/2010	Novel phospholipid analogues of pan-PPAR activator tetradecylthioacetic acid are more PPAR alpha selective.
2/2009	Synthesis and analysis of novel glycerolipids for the treatment of metabolic syndrome.
6/2002	Metabolic effects of thia fatty acids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jon Skorve Research Topics

Disease

8	Inflammation (Inflammations) 05/2020 - 02/2009
6	Insulin Resistance 05/2020 - 06/2002
3	Fatty Liver 01/2021 - 10/2013
3	Body Weight (Weight, Body) 01/2019 - 09/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2020 - 02/2016
2	Non-alcoholic Fatty Liver Disease 05/2020 - 02/2016
2	Obesity 05/2020 - 12/2018
2	Dyslipidemias (Dyslipidemia) 05/2020 - 07/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2020 - 01/2011
2	Atherosclerosis 01/2014 - 03/2002
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Abdominal Obesity 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2011
1	Colitis 02/2011
1	Ulcerative Colitis 02/2011

Drug/Important Bio-Agent (IBA)

12	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 06/2002
6	LipidsIBA 01/2021 - 02/2009
4	AntioxidantsIBA 05/2020 - 03/2002
4	1-(carboxymethylthio)tetradecaneIBA 07/2011 - 06/2002
2	1-(carboxyethylthio)tetradecaneIBA 05/2020 - 02/2016
2	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 09/2009
2	HomocysteineIBA 02/2016 - 02/2011
2	EnzymesIBA 01/2014 - 10/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 10/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2010 - 02/2009
1	ApolipoproteinsIBA 01/2021
1	OilsIBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	NAD (NADH)IBA 05/2020
1	Niacinamide (Nicotinamide)FDA LinkGeneric 05/2020
1	KynurenineIBA 05/2020
1	2-(tridec-12-yn-1-ylthio)acetic acidIBA 01/2019
1	Peptides (Polypeptides)IBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 12/2018
1	Protein Hydrolysates FDA Link 12/2018
1	thiamine triphosphorate (TTP)IBA 02/2016
1	CarbonIBA 02/2016
1	SphingolipidsIBA 08/2015
1	Fish OilsIBA 08/2015
1	Caseins (Casein)FDA Link 01/2014
1	Apolipoproteins E (ApoE)IBA 01/2014
1	Carnitine (L-Carnitine)FDA LinkGeneric 10/2013
1	Fish ProteinsIBA 10/2013
1	AcidsIBA 10/2013
1	PowdersIBA 10/2012
1	EicosanoidsIBA 07/2011
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 02/2011
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2011
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 01/2011
1	Messenger RNA (mRNA)IBA 09/2009
1	LeptinIBA 09/2009
1	Conjugated Linoleic AcidsIBA 09/2009
1	Biological ProductsIBA 06/2002
1	oxidized low density lipoproteinIBA 03/2002

Therapy/Procedure

1	Glycemic Control 01/2021